Top

Published in:

01-05-2009 | Original Research Article

Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre

Authors: Dr Annie Pierre Jonville-Béra, Hassan Saissi, Lamiae Bensouda-Grimaldi, Frederique Beau-Salinas, Haware Cissoko, Bruno Giraudeau, Elisabeth Autret-Leca

Published in: Drug Safety | Issue 5/2009

Abstract

Background: Adverse drug reactions (ADRs) are now recognized as a major category of iatrogenic illness in terms of morbidity and mortality. Objective: To describe the type and frequency of avoidable ADRs spontaneously reported to a regional drug monitoring centre following inappropriate prescribing, as a basis for preventive actions.

Methods: A prospective, observational study of ADRs reported to the Regional Drug Monitoring Centre of Tours, France, between 26 November 2002 and 28 November 2003. The outcome measure was ADRs secondary to inappropriate prescribing that were defined as entirely or partly avoidable, i.e. at least one of the recommendations in various sections of the summary of product characteristics (SPC; indication, route of administration, dose, duration of treatment, dose adaptation, precautions for use, monitoring of treatment, absolute contraindications and contraindicated interactions) had not been respected. The link between the lack of conformity of the drug prescription with the SPC and occurrence of the ADR was evaluated by a working group using two criteria: (i) is nonconformity of the prescription of this drug a known and validated risk factor for this ADR?; and (ii) are there other aetiologies or other risk factors for this ADR?

Results: Three hundred and sixty ADRs in 294 adults and 66 children were analysed. The prescription was considered inappropriate for 213 of the 659 (32%) drugs implicated in ADRs, corresponding to 161 patients (45%). The ADR was adjudged entirely avoidable for 32 (9%) patients, partly avoidable for 28 (8%) patients and unavoidable for 300 (83%) patients. Not taking into account a history of allergy or altered renal function and not respecting the recommended dose were the most frequent causes of entirely avoidable ADRs. Allopurinol and lamotrigine were the drugs most frequently involved in serious avoidable ADRs.

Conclusions: Preventive actions should focus on more systematic allergy checks when prescribing drugs and on dose adaptation in cases of altered renal function.

Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000; 55: 181–6CrossRef

Olivier P, Boulbès O, Tubery M, et al. Evitabilité des effets indésirables dans un service d’admissions médicales. Therapie 2001; 56: 275–8PubMedCrossRef

Bannwarth B, Queneau P, Carpentier F, et al. Hospital visits caused by adverse drug reactions. Drug Saf 2003; 26: 133–4PubMedCrossRef

Peyriere H, Cassan S, Floutard E, et al. Adverse drug events associated with hospital admission. Ann Pharmacother 2003; 37: 5–10PubMedCrossRef

Law no. 2004–806 of August 9,2004 relating to the policy of public health. Hundred objectives of public health. J Off Repub Fr Ed Lois Decrets 2004 Aug; (185): 14277

Thürmann PA. Prescribing errors resulting in adverse drug events: how can they be prevented? Expert Opin Drug Saf 2006; 5: 489–93PubMedCrossRef

Bégaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des medicaments: actualisation de la méthode utilisée en France. Therapie 1985; 40: 111–8PubMed

Jonville-Bera AP, Bera F, Autret-Leca E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur J Clin Pharmacol 2005; 61: 231–6PubMedCrossRef

Standardization of definitions and criteria of causality assessment of adverse drug reactions: drug-induced cytopenia. nt J Clin Pharmacol Ther Toxicol1991; 29: 75–81

10.

Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990; 11: 272–6PubMedCrossRef

11.

Vigeral P, Baumelou A, Bénichou C, et al. Drug-induced renal insufficiency: results of consensus meetings [in French]. Nephrologie 1989; 10: 157–61PubMed

12.

Fournier M, Camus P, Benichou C, et al. Interstitial pneumopathies: criteria of drug side-effects: results of consensus meetings [in French]. Presse Med 1989; 18: 1333–6PubMed

13.

Guillaume JC, Roujeau JC, Chevrant-Breton J, et al. How to diagnose a cutaneous complication of a drug: application to vascular purpura [in French]. Ann Dermatol Venereol 1987; 114: 721–4PubMed

14.

Habibi B, Solal-Celigny P, Benichou C, et al. Drug-induced hemolytic anemia: results of consensus conferences [in French]. Therapie 1988; 43: 117–20PubMed

15.

Dictionnaire vidal. 78th rev. ed. Paris: Editions du Vidal, 2002

16.

Kanjanarat P, Winterstein AG, Johns TE, et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003; 60: 1750–9PubMed

17.

Von Laue NC, Schwappach DLB, Koech CM. The epidemiology of medical errors: a review of the literature. Wien Klin Wochenschr 2003; 115: 318–5CrossRef

18.

Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med 1988; 109: 582–9PubMed

19.

Hallas J, Harvarld B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83–90PubMedCrossRef

20.

Petersen LA, Brennan TA, O’Neil AC, et al. Does housestaff discontinuity of care increase the risk for preventable adverse events? Ann Intern Med 1994; 121: 866–72PubMed

21.

Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29–34PubMedCrossRef

22.

Cunningham G, Dodd TRP, Grant DJ, et al. Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997; 26: 375–82PubMedCrossRef

23.

Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions [letter]. Hosp Pharm 1992; 27: 538PubMed

24.

Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268–72PubMed

25.

Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701–7PubMed

26.

Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931–4PubMedCrossRef

27.

McDonnell P, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331–2PubMedCrossRef

28.

Lau PM, Stewart K, Dooley MJ. Hospital admissions resulting from preventable adverse drug reactions [comment]. Ann Pharmacother 2003; 37: 303–4PubMedCrossRef

29.

Courtman BJ, Stallings SB. Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm 1995; 48: 161–6PubMed

30.

Dartnell JGA, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 659–62PubMed

31.

Bero LA, Lipton HL, Adair Bird J. Characterization of geriatric drug-related hospital readmissions. Med Care 1991; 29: 989–1003PubMedCrossRef

32.

Imbs JL, Pletan Y, Spriet A, et al. Les membres de la table ronde n∘2 de Giens XIII: evaluation de la iatrogénie médicamenteuse évitable: méthodologie. Therapie 1998; 53: 365–70PubMed

33.

Olivier P, Caron J, Haramburu F, et al. Validation d’une échelle de mesure: exemple de l’échelle française d’évitabilité des effets indésirables médicamenteux. Therapie 2005; 60: 39–45PubMedCrossRef

34.

National Council focuses on coordinating error reduction efforts. USP quality review 1997, 57 [online]. Available from URL: http://www.usp.org/hqi/practitionerPrograms/newsletters/qualityReview/qr571997-01-01e.html [Accessed 2009 Feb 1]

35.

Trunet P, Le Gall JR, Lhoste F, et al. The role of iatrogenic disease in admissions to intensive care. JAMA 1980; 244: 2617–20PubMedCrossRef

36.

Trunet P, Borda IT, Rouget AV, et al. The role of drug-induced illness in admissions to an intensive care unit. Intensive Care Med 1986; 12: 43–6PubMedCrossRef

37.

Darchy B, Le Mière E, Figueredo B, et al. Iatrogenic diseases as a reason for admission to the intensive care unit. Arch Intern Med 1999; 159: 71–8PubMedCrossRef

38.

Letrilliart L, Hanslik T, Biour M, et al. Postdischarge adverse drug reactions in primary care originating from hospital care in France. Drug Saf 2001; 24: 781–92PubMedCrossRef

39.

Imbs JL, Pouyanne P, Haramburu F, et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie 1999; 54: 21–7PubMed

40.

Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 2000; 320: 741–4PubMedCrossRef

41.

Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767–7PubMedCrossRef

42.

Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107–16PubMedCrossRef

43.

Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300PubMedCrossRef

44.

Fantino B, Voirin N, Laforest L, et al. Primary care physicians’ behaviors toward risk of iatrogenesis in elderly patients. Eur J Clin Pharmacol 2006; 62: 563–70PubMedCrossRef

45.

Temple ME, Robinson RF, Miller JC, et al. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 819–29PubMedCrossRef

46.

Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277: 312–7PubMedCrossRef

47.

Winterstein AG, Hatton RC, Gonzalez-Rothi R, et al. Identifying clinically significant preventable adverse drug events through a hospital’s database of drug reaction reports. Am J Health Syst Pharm 2002; 59: 1742–9PubMed

48.

Jones TA, Como JA. Assessment of medication errors that involved drug allergies at a university hospital. Pharmacotherapy 2003; 23: 855–60PubMedCrossRef

49.

Krähenbühl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf 2007; 30: 379–407PubMedCrossRef

50.

Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995; 274: 35–43PubMedCrossRef

51.

Dean B, Schachter M, Vincent C, et al. Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care 2002; 11: 340–4PubMedCrossRef

52.

Corsonello A, Pedone C, Corica F, et al. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790–5PubMedCrossRef

53.

Fauchais AL, Ploquin I, Ly K, et al. Iatrogénie chez le sujet âgé de plus de 75 ans dans un service de posturgences: etude prospective de cohorte avec suivi à six mois. Rev Med Interne 2006; 27: 375–81PubMedCrossRef

54.

Salomon L, Deray G, Jaudon MC, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 2003; 15: 331–5PubMedCrossRef

55.

Salomon L, Levu S, Deray G, et al. Assessing residents’ prescribing behavior in renal impairment. Int J Qual Health Care 2003; 15: 235–40PubMedCrossRef

56.

Smith P, Karlson N, Nair BR. Quality use of allopurinol in the elderly. J Qual Clin Pract 2000; 20: 42–3PubMedCrossRef

57.

Mikuls TR, Curtis JR, Allison JJ, et al. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous internet-accessible error reporting system. J Rheumatol 2006; 33: 562–6PubMed

58.

Perez-Ruiz F, Hernando I, Villar I, et al. Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity. J Clin Rheumatol 2005; 11: 129–33PubMedCrossRef

59.

Gutierrez-Macias A, Lizarralde-Palacios E, Martinez-Odriozola P, et al. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005; 331: 623–4PubMedCrossRef

60.

Chao SC, Yang CC, Lee JY. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease. Ann Pharmacother 2005; 39: 1552–6PubMedCrossRef

61.

Arellano F, Sacristán JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 337–43PubMed

62.

Kumar A, Edward N, White MI, et al. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 1996; 312: 173–4PubMedCrossRef

63.

Hirsch LJ, Weintraub DB, Buchsbaum R, et al. Predictors of lamotrigine-associated rash. Epilepsia 2006; 47: 318–22PubMedCrossRef

Title: Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre
Authors: Dr Annie Pierre Jonville-Béra
Hassan Saissi
Lamiae Bensouda-Grimaldi
Frederique Beau-Salinas
Haware Cissoko
Bruno Giraudeau
Elisabeth Autret-Leca
Publication date: 01-05-2009
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 5/2009
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200932050-00006

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Avoidability of Adverse Drug Reactions Spontaneously Reported to a French Regional Drug Monitoring Centre

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2009

Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin

Hypoglycaemia with Oral Antidiabetic Drugs

Effect of Date of Drug Marketing on Disproportionality Measures in Pharmacovigilance

Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome

Data Mining in Pharmacovigilance -Detecting the Unexpected

Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients